Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers.

Journal of acquired immune deficiency syndromes (1999)

Volumn 61, Issue 3, 2012, Pages 310-316

  Huang, Liusheng ^a   Parikh, Sunil ^b   Rosenthal, Philip J ^b   Lizak, Patricia ^b   Marzan, Florence ^b   Dorsey, Grant ^b   Havlir, Diane ^b   Aweeka, Francesca T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; BENZOXAZINE DERIVATIVE; DIHYDROARTEMISININ; EFAVIRENZ; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG COMBINATION; DRUG INTERACTION; FEMALE; HUMAN; MALE; MIDDLE AGED;

ADULT; ANTI-HIV AGENTS; ANTIMALARIALS; ARTEMISININS; BENZOXAZINES; CROSS-OVER STUDIES; DRUG COMBINATIONS; DRUG INTERACTIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

MLCS; MLOWN;

EID: 85027955343     PISSN: None     EISSN: 19447884     Source Type: Journal    
DOI: 10.1097/qai.0b013e31826ebb5c     Document Type: Article

References (0)